- Drug Today Medical Times
As is reported in a national daily, harmful fixed dose combinations (FDCs) are entering the Indian market unhindered. This would not have been possible without loopholes in the Indian Drug Act. If this was not the case, how could these FDCs skip Central Drugs Standard Control Organization's (CDSCO) scrutiny and National Pharmaceutical Pricing Authority's (NPPA) price control regime?
According to the report, many of the FDCs are available without necessary clinical trials, and with little medical rationale. Both CDSCO and NPPA have miserably failed to in their job. However, rather than taking steps to stem the rot in the industry, National Pharmaceutical Pricing Authority (NPPA) seems obsessed with populism.
The drug regulators are giving jitters to an industry which is already in crisis by imposing undue restrictions on the drug manufacturers and placing essential drugs in the long list of price control. These measures are making the pharma business unviable option for investors.
Drug Today Medical Times is provides The best Drug manufacturers company in India, Pharmacological Index, Pharmacological Research, India's No.1 Health newspaper, latest paramedical and pharmaceutical news, Health and medical AIIMS, A to z medicine in India, Meaning of pharmacological, Pronunciation of pharmacological, Translations of pharmacological, Pharmacological synonyms, pharmacological antonyms, latest medical news, Drug Directory and Pharma Jobs, drug today book and Subscription at http://www.drugtodayonline.com/
No comments:
Post a Comment